US Stock MarketDetailed Quotes

PTIX Protagenic Therapeutics

Watchlist
  • 0.3876
  • -0.0304-7.27%
Close Apr 4 16:00 ET
  • 0.3050
  • -0.0826-21.31%
Post 20:01 ET
2.92MMarket Cap-0.34P/E (TTM)

Protagenic Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
25.93%5.7M
35.55%1.64M
-54.46%652.07K
45.78%1.67M
135.14%1.74M
27.24%4.53M
84.85%1.21M
54.94%1.43M
79.64%1.14M
-44.88%739.29K
Selling and administrative expenses
45.69%1.76M
268.44%739.82K
-6.44%287.88K
47.48%453.3K
-29.05%277.61K
-38.68%1.21M
-49.58%200.8K
-27.21%307.68K
-35.45%307.36K
-41.73%391.26K
-General and administrative expense
45.69%1.76M
268.44%739.82K
-6.44%287.88K
47.48%453.3K
-29.05%277.61K
-38.68%1.21M
-49.58%200.8K
-27.21%307.68K
-35.45%307.36K
-41.73%391.26K
Research and development costs
18.75%3.94M
-10.68%903.36K
-67.60%364.18K
45.16%1.21M
319.72%1.46M
108.90%3.32M
292.76%1.01M
124.19%1.12M
421.06%836.38K
-48.04%348.03K
Operating profit
-25.93%-5.7M
-35.55%-1.64M
54.46%-652.07K
-45.78%-1.67M
-135.14%-1.74M
-27.24%-4.53M
-84.85%-1.21M
-54.94%-1.43M
-79.64%-1.14M
44.88%-739.29K
Net non-operating interest income expense
-72.28%43.47K
-77.88%9.03K
-69.72%11.28K
-82.50%9.29K
-45.90%13.87K
224.40%156.79K
-32.52%40.81K
253.55%37.26K
881.20%53.1K
261.43%25.63K
Non-operating interest income
-83.57%43.47K
-83.18%9.03K
-83.70%11.28K
-89.03%9.29K
-75.63%13.87K
42.35%264.48K
-41.95%53.66K
62.88%69.22K
157.47%84.71K
216.65%56.89K
Non-operating interest expense
--0
--0
--0
--0
--0
-21.66%107.68K
-59.78%12.85K
0.00%31.96K
-20.37%31.61K
-7.63%31.26K
Other net income (expense)
120.96%132.14K
115.93%80.41K
143.33%51.53K
104.47%198
-1,268.74%-630.32K
-8,222.56%-504.76K
81.54%-2.18K
-411.69%-118.95K
10.57%-4.43K
Gain on sale of security
108.21%51.73K
--0
----
143.33%51.53K
104.47%198
-1,268.74%-630.32K
-7,876.31%-483.76K
-96.66%-23.18K
-411.69%-118.95K
10.57%-4.43K
Other non- operating income (expenses)
--80.41K
----
----
----
----
----
----
--21K
----
----
Income before tax
-10.50%-5.53M
7.30%-1.55M
54.12%-640.79K
-32.82%-1.61M
-140.12%-1.72M
-40.64%-5M
-178.73%-1.68M
-50.94%-1.4M
-81.42%-1.21M
47.28%-718.1K
Income tax
0
0
0
0
0
0
0
0
0
0
Net income
-10.50%-5.53M
7.30%-1.55M
54.12%-640.79K
-32.82%-1.61M
-140.12%-1.72M
-40.64%-5M
-178.73%-1.68M
-50.94%-1.4M
-81.42%-1.21M
47.28%-718.1K
Net income continuous Operations
-10.50%-5.53M
7.30%-1.55M
54.12%-640.79K
-32.82%-1.61M
-140.12%-1.72M
-40.64%-5M
-178.73%-1.68M
-50.94%-1.4M
-81.42%-1.21M
47.28%-718.1K
Minority interest income
Net income attributable to the parent company
-10.50%-5.53M
7.30%-1.55M
54.12%-640.79K
-32.82%-1.61M
-140.12%-1.72M
-40.64%-5M
-178.73%-1.68M
-50.94%-1.4M
-81.42%-1.21M
47.28%-718.1K
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-10.50%-5.53M
7.30%-1.55M
54.12%-640.79K
-32.82%-1.61M
-140.12%-1.72M
-40.64%-5M
-178.73%-1.68M
-50.94%-1.4M
-81.42%-1.21M
47.28%-718.1K
Basic earnings per share
1.74%-1.13
36.84%-0.24
56.25%-0.14
-28.57%-0.36
-129.41%-0.39
-40.24%-1.15
-171.43%-0.38
-52.38%-0.32
-86.67%-0.28
46.88%-0.17
Diluted earnings per share
1.74%-1.13
36.84%-0.24
56.25%-0.14
-28.57%-0.36
-129.41%-0.39
-40.24%-1.15
-171.43%-0.38
-52.38%-0.32
-86.67%-0.28
46.88%-0.17
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 25.93%5.7M35.55%1.64M-54.46%652.07K45.78%1.67M135.14%1.74M27.24%4.53M84.85%1.21M54.94%1.43M79.64%1.14M-44.88%739.29K
Selling and administrative expenses 45.69%1.76M268.44%739.82K-6.44%287.88K47.48%453.3K-29.05%277.61K-38.68%1.21M-49.58%200.8K-27.21%307.68K-35.45%307.36K-41.73%391.26K
-General and administrative expense 45.69%1.76M268.44%739.82K-6.44%287.88K47.48%453.3K-29.05%277.61K-38.68%1.21M-49.58%200.8K-27.21%307.68K-35.45%307.36K-41.73%391.26K
Research and development costs 18.75%3.94M-10.68%903.36K-67.60%364.18K45.16%1.21M319.72%1.46M108.90%3.32M292.76%1.01M124.19%1.12M421.06%836.38K-48.04%348.03K
Operating profit -25.93%-5.7M-35.55%-1.64M54.46%-652.07K-45.78%-1.67M-135.14%-1.74M-27.24%-4.53M-84.85%-1.21M-54.94%-1.43M-79.64%-1.14M44.88%-739.29K
Net non-operating interest income expense -72.28%43.47K-77.88%9.03K-69.72%11.28K-82.50%9.29K-45.90%13.87K224.40%156.79K-32.52%40.81K253.55%37.26K881.20%53.1K261.43%25.63K
Non-operating interest income -83.57%43.47K-83.18%9.03K-83.70%11.28K-89.03%9.29K-75.63%13.87K42.35%264.48K-41.95%53.66K62.88%69.22K157.47%84.71K216.65%56.89K
Non-operating interest expense --0--0--0--0--0-21.66%107.68K-59.78%12.85K0.00%31.96K-20.37%31.61K-7.63%31.26K
Other net income (expense) 120.96%132.14K115.93%80.41K143.33%51.53K104.47%198-1,268.74%-630.32K-8,222.56%-504.76K81.54%-2.18K-411.69%-118.95K10.57%-4.43K
Gain on sale of security 108.21%51.73K--0----143.33%51.53K104.47%198-1,268.74%-630.32K-7,876.31%-483.76K-96.66%-23.18K-411.69%-118.95K10.57%-4.43K
Other non- operating income (expenses) --80.41K--------------------------21K--------
Income before tax -10.50%-5.53M7.30%-1.55M54.12%-640.79K-32.82%-1.61M-140.12%-1.72M-40.64%-5M-178.73%-1.68M-50.94%-1.4M-81.42%-1.21M47.28%-718.1K
Income tax 0000000000
Net income -10.50%-5.53M7.30%-1.55M54.12%-640.79K-32.82%-1.61M-140.12%-1.72M-40.64%-5M-178.73%-1.68M-50.94%-1.4M-81.42%-1.21M47.28%-718.1K
Net income continuous Operations -10.50%-5.53M7.30%-1.55M54.12%-640.79K-32.82%-1.61M-140.12%-1.72M-40.64%-5M-178.73%-1.68M-50.94%-1.4M-81.42%-1.21M47.28%-718.1K
Minority interest income
Net income attributable to the parent company -10.50%-5.53M7.30%-1.55M54.12%-640.79K-32.82%-1.61M-140.12%-1.72M-40.64%-5M-178.73%-1.68M-50.94%-1.4M-81.42%-1.21M47.28%-718.1K
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -10.50%-5.53M7.30%-1.55M54.12%-640.79K-32.82%-1.61M-140.12%-1.72M-40.64%-5M-178.73%-1.68M-50.94%-1.4M-81.42%-1.21M47.28%-718.1K
Basic earnings per share 1.74%-1.1336.84%-0.2456.25%-0.14-28.57%-0.36-129.41%-0.39-40.24%-1.15-171.43%-0.38-52.38%-0.32-86.67%-0.2846.88%-0.17
Diluted earnings per share 1.74%-1.1336.84%-0.2456.25%-0.14-28.57%-0.36-129.41%-0.39-40.24%-1.15-171.43%-0.38-52.38%-0.32-86.67%-0.2846.88%-0.17
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP

Market Insights

Best Growth Stocks Best Growth Stocks

Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

No. Symbol Price
Ermenegildo Zegna NV
ZGN
6.600
YETI Holdings
YETI
30.150
DOMINOS PIZZA ENTERPRISES LIMITED UNSP ADR EACH REPR 0.5 ORD SHS
DMZPY
7.880
4
Cars.com
CARS
10.720
5
LIFE HEALTHCARE GROUP HOLDINGS UNSPON ADR EA REPR 4 ORD ZAR0.00
LTGHY
2.840
Log In for the Full List
Unlock Now

Investment Course

Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.

Discussing

Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context, Show More
MicroStrategy Q4 2024 earnings conference call

Monetary Policy: Navigating the Fed's Rate Cut Cycle

Changing Fed policy is altering the market math for investors.